IDH mutations are generally rare in some common cancers (breast, prostate and gastric), apart from some rare sub-types such as Breast Solid Papillary carcinoma with reverse polarity, where 77% of cases have IDH2 mutations [47]. Here, IDH1 is linked to cancer.